Definitive molecular diagnosis of facioscapulohumeral dystrophy

Neurology

Volumn 52, Issue 9, 1999, Pages 1822-1826

  Orrell, R W ^a   Tawil, R ^a   Forrester, J ^b   Kissel, J T ^c   Mendell, J R ^d   Figlewicz, D A ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CHROMOSOME 10Q; CHROMOSOME 4Q; CHROMOSOME DELETION; CONTROLLED STUDY; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RESTRICTION FRAGMENT; TELOMERE;

EID: 0032976224     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.9.1822     Document Type: Article

References (22)

1. The FSH-DY Group. A prospective, quantitative study of the natural history of faeioscapulohumeral muscular dystrophy (FSHD): implications for therapeutic trials. Neurology 1997; 48:38-46.
2. Tawil R, Griggs RC. Faeioscapulohumeral muscular dystrophy. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL, eds. The molecular and genetic basis of neurological disease, 2nd ed. Boston: Butterworth-Heinemann, 1997:931-938.
3. Wijmenga C, Frants RR, Brouwer OF, Moerer P, Weber JL, Padberg GW. Location of faeioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet 1990;336:651-653.
4. Weiffenbach B, Bagley R, Falls K, et al. Linkage analyses of five chromosome 4 markers localizes the facioscapulohumeral muscular dystrophy (FSHD) gene to distal 4q35. Am J Hum Genet 1992;51:416-423.
5. Wijmenga C, Hewitt JE, Sandkuijl LA, et al. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nature Genet 1992;2:26-30.
6. Upadhyaya M, Jardine P, Maynard J, et al. Molecular analysis of British facioscapulohumeral dystrophy families for 4q DNA rearrangements. Hum Mol Genet 1993;2:981-987.
7. Weiffenbach B, Dubois J, Storvick D, et al. Mapping the facioscapulohumeral muscular dystrophy gene is complicated by chromosome 4q35 recombination events. Nature Genet 1993; 4:165-169.
8. van Deutekom JCT, Wijmenga C, van Tienhoven EAE, et al. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum Mol Genet 1993;2:2037-2042.
9. Hewitt JE, Lyle R, Clark LN, et al. Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. Hum Mol Genet 1994;3:1287-1295.
10. Bakker E, Wijmenga C, Vossen RH, et al. The FSHD-Iinked locus D4F104S1 (pl3E-ll) on 4q35 has a homologue on lOqter. Muscle Nerve 1995;2(suppl):S39-S44.
11. Deidda G, Cacurri S, Piazzo N, Felicetti L. Direct detection of 4q35 rearrangements implicated in facioscapulohumeral muscular dystrophy (FSHD). J Med Genet 1996;33:361-365.
12. Tawil R, McDermott MP, Mendell JR, Kissell J, Griggs RC, FSH-DY Group. Facioscapulohumeral muscular dystrophy (FSHD): design of natural history study and results of baseline testing. Neurology 1994;44:442-446.
13. Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci USA 1984;81:1991-1995.
14. Griggs RC, Tawil R, Storvick D, Mendell JR, Altherr MR. Genetics of facioscapulohumeral muscular dystrophy: new mutations in sporadic cases. Neurology 1993;43:2369-2372.
15. Upadhyaya M, Maynard J, Rogers MT, et al. Improved molecular diagnosis of facioscapulohumeral muscular dystrophy (FSHD): validation of the differential double digestion for FSHD. J Med Genet 1997;34:476-479.
16. van Deutekom JCT, Bakker E, Lemmers RJLF, et al. Evidence for subtelomeric exchange of 3.3 kb tandemly repeated units between chromosomes 4q35 and 10q26: implications for genetic counselling and etiology of FSHD1. Hum Mol Genet 1996;5:1997-2003.
17. Lemmers RJLF, van der Maarel SM, van Deutekom JCT, et al. Inter- and intrachromosomal sub-telomeric rearrangements on 4q35: implications for facioscapulohumeral muscular dystrophy (FSHD) aetiology and diagnosis. Hum Mol Genet 1998;7:1207-1214.
18. Lunt PW, Jardine PE, Koch MC, et al. Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD). Hum Mol Genet 1995;4:951-958.
19. Tawil R, Forrester J, Griggs RC, et al. Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. Ann Neurol 1996;39: 744-748.
20. Gilbert JR, Stajich JM, Wall S, et al. Evidence for heterogeneity in facioscapulohumeral muscular dystrophy (FSHD). Am J Hum Genet 1993;53:401-408.
21. Cacurri S, Piazzo N, Deidda G, et al. Sequence homology between 4qter and lOqter loci facilitates the instability of subtelomeric Kpnl repeat units implicated in facioscapulohumeral muscular dystrophy. Am J Hum Genet 1998;63: 181-190.
22. Kissell JT, McDermott M, Natarajan MA, et al. Open-label trial of albuterol in facioscapulohumeral muscular dystrophy. Neurology 1998;50:1402-1406.